Artbio

is a Massachusetts-based radiopharmaceutical company that researches and develops alpha radioligand therapies for the treatment of cancer...
Read more
Artbio CEO: Emanuele Ostuni

CEO

Emanuele Ostuni

CEO Approval Rating

90/100

2021

PrivateIndependent Company

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$113M

Artbio Competitors

1POINT
2Fusion Pharma
3Orano Med
4Telix
5QBioMed
6SpaceOAR
7RayzeBio
8Athenex
9ARMO BioSciences
10Progenics
See 16+ competitors